Area of research
Cancer Research · Molecular Biology
Research interest
Research focused on Breast cancer and Cancer research, with related work in GPX4, Cancer, Long non-coding RNA. Notable publications include 'Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin', 'Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells', and 'Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer'.
Long non-coding RNA NORAD serves as a promoter of oncogenesis and inhibits ferroptosis via miR-144-3p-mTOR-ferritinophagy axis in cancer
NAT10/ac4C/JunB facilitates TNBC malignant progression and immunosuppression by driving glycolysis addiction
Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression
Targeting Histone Modifications in Breast Cancer: A Precise Weapon on the Way
Long Noncoding RNAs Control the Modulation of Immune Checkpoint Molecules in Cancer
Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin
Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells
Ai-lncRNA EGOT enhancing autophagy sensitizes paclitaxel cytotoxicity via upregulation of ITPR1 expression by RNA-RNA and RNA-protein interactions in human cancer
The transcriptional landscape of lncRNAs reveals the oncogenic function of LINC00511 in ER-negative breast cancer
Upregulation of DLEU1 expression by epigenetic modification promotes tumorigenesis in human cancer
Modulation of autophagy in human diseases strategies to foster strengths and circumvent weaknesses
Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer.
PubMed 2015cited by 151position: middle
Downregulation of the long noncoding RNA EGOT correlates with malignant status and poor prognosis in breast cancer